3/22
04:02 pm
hims
Nvidia's valuation forecasts aren't 'justified': Portfolio manager [Yahoo! Finance]
Low
Report
Nvidia's valuation forecasts aren't 'justified': Portfolio manager [Yahoo! Finance]
3/21
11:37 am
hims
Hims & Hers: 5 Reasons Why This Is A Phenomenal Long-Term Growth Stock [Seeking Alpha]
Low
Report
Hims & Hers: 5 Reasons Why This Is A Phenomenal Long-Term Growth Stock [Seeking Alpha]
3/18
02:29 am
hims
Hims & Hers Health: A Lesson In Psychology [Seeking Alpha]
Medium
Report
Hims & Hers Health: A Lesson In Psychology [Seeking Alpha]
3/12
04:42 pm
hims
Pills Pay The Bills: Mini Deep Dive On Hims & Hers Health [Seeking Alpha]
Medium
Report
Pills Pay The Bills: Mini Deep Dive On Hims & Hers Health [Seeking Alpha]
3/11
08:00 am
hims
Hims & Hers to Participate in Canaccord Genuity's Virtual eCommerce Sustainable Advantage Forum on March 14, 2024
Low
Report
Hims & Hers to Participate in Canaccord Genuity's Virtual eCommerce Sustainable Advantage Forum on March 14, 2024
3/8
01:42 am
hims
Insider Sell: COO Melissa Baird Sells 35,253 Shares of Hims & Hers Health Inc (HIMS) [Yahoo! Finance]
Low
Report
Insider Sell: COO Melissa Baird Sells 35,253 Shares of Hims & Hers Health Inc (HIMS) [Yahoo! Finance]
3/5
06:21 pm
hims
Hims & Hers Health, Inc. (NYSE: HIMS) was upgraded by analysts at TheStreet from a "d" rating to a "c" rating.
Medium
Report
Hims & Hers Health, Inc. (NYSE: HIMS) was upgraded by analysts at TheStreet from a "d" rating to a "c" rating.
3/5
01:18 pm
hims
What Makes Hims & Hers Health, Inc. (HIMS) a Strong Momentum Stock: Buy Now? [Yahoo! Finance]
Neutral
Report
What Makes Hims & Hers Health, Inc. (HIMS) a Strong Momentum Stock: Buy Now? [Yahoo! Finance]
3/3
08:24 am
hims
Hims & Hers Health Surges 30% After Earnings. Here Is Why the Stock Is Still a Magnificent Buy. [Yahoo! Finance]
High
Report
Hims & Hers Health Surges 30% After Earnings. Here Is Why the Stock Is Still a Magnificent Buy. [Yahoo! Finance]
2/29
01:54 pm
hims
Why Hims & Hers Health, Inc. (HIMS) Might be Well Poised for a Surge [Yahoo! Finance]
Low
Report
Why Hims & Hers Health, Inc. (HIMS) Might be Well Poised for a Surge [Yahoo! Finance]
2/29
12:18 pm
hims
Hims & Hers Health: The Convergence Begins [Seeking Alpha]
Low
Report
Hims & Hers Health: The Convergence Begins [Seeking Alpha]
2/28
08:46 am
hims
Hims & Hers Health, Inc. (NYSE:HIMS) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Hims & Hers Health, Inc. (NYSE:HIMS) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
2/28
07:30 am
hims
Hims & Hers Health, Inc. (NYSE: HIMS) was upgraded by analysts at Imperial Capital from an "in-line" rating to an "outperform" rating. They now have a $16.00 price target on the stock.
Low
Report
Hims & Hers Health, Inc. (NYSE: HIMS) was upgraded by analysts at Imperial Capital from an "in-line" rating to an "outperform" rating. They now have a $16.00 price target on the stock.
2/28
12:31 am
hims
US stocks close mixed ahead of revised US growth data and big lineup of Fed speakers [Yahoo! Finance]
Medium
Report
US stocks close mixed ahead of revised US growth data and big lineup of Fed speakers [Yahoo! Finance]
2/27
12:12 pm
hims
Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Citigroup Inc. from $12.00 to $16.00. They now have a "buy" rating on the stock.
Low
Report
Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Citigroup Inc. from $12.00 to $16.00. They now have a "buy" rating on the stock.
2/27
12:12 pm
hims
Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Guggenheim from $15.00 to $17.00. They now have a "buy" rating on the stock.
Low
Report
Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Guggenheim from $15.00 to $17.00. They now have a "buy" rating on the stock.
2/27
10:55 am
hims
Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Piper Sandler from $9.00 to $11.00. They now have a "neutral" rating on the stock.
Low
Report
Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Piper Sandler from $9.00 to $11.00. They now have a "neutral" rating on the stock.
2/27
10:55 am
hims
Is Hims & Hers Health Stock Still a Buy After Strong Earnings? [Yahoo! Finance]
Low
Report
Is Hims & Hers Health Stock Still a Buy After Strong Earnings? [Yahoo! Finance]
2/27
10:34 am
hims
Hims & Hers Stock Surges After Earnings. Wall Street Sees More Growth. [MarketWatch]
Low
Report
Hims & Hers Stock Surges After Earnings. Wall Street Sees More Growth. [MarketWatch]
2/27
09:00 am
hims
Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Truist Financial Co. from $10.00 to $13.00. They now have a "hold" rating on the stock.
High
Report
Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Truist Financial Co. from $10.00 to $13.00. They now have a "hold" rating on the stock.
2/27
05:56 am
hims
Hims & Hers Health, Inc. (NYSE: HIMS) had its "market perform" rating re-affirmed by analysts at Leerink Partnrs.
Medium
Report
Hims & Hers Health, Inc. (NYSE: HIMS) had its "market perform" rating re-affirmed by analysts at Leerink Partnrs.
2/26
05:08 pm
hims
Hims & Hers Health Inc (HIMS) Reports Strong Revenue Growth and Achieves Profitability in ... [Yahoo! Finance]
High
Report
Hims & Hers Health Inc (HIMS) Reports Strong Revenue Growth and Achieves Profitability in ... [Yahoo! Finance]
2/26
04:22 pm
hims
Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]
High
Report
Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]
2/26
04:05 pm
hims
Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
High
Report
Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
2/26
08:21 am
hims
Hims & Hers Health, Inc. (NYSE: HIMS) is now covered by analysts at SVB Leerink LLC. They set a "market perform" rating and a $10.00 price target on the stock.
Medium
Report
Hims & Hers Health, Inc. (NYSE: HIMS) is now covered by analysts at SVB Leerink LLC. They set a "market perform" rating and a $10.00 price target on the stock.